| A |
|
Margaret Anderson
Executive Director, FasterCures
Jana Armstrong
Executive Director, Drugs for Neglected Diseases initiative North America
Mara G. Aspinall
President and CEO, On-Q-Ity
Christopher P. Austin, M.D.
Director, NIH Chemical Genomics Center
|
| |
| B |
|
Dana Ball
Program Director, The Leona M. & Harry B. Helmsley Charitable Trust
Alex Barkas
Managing Director, Prospect Venture Partners
Robert J. Beall, Ph.D.
President and CEO, Cystic Fibrosis Foundation
Sharon Begley
Senior Editor, Newsweek
Melanie Schnoll Begun
Managing Director, Morgan Stanley Smith Barney Philanthropic Services
Peter H. Bell
Executive Vice President, Programs and Services Autism Speaks
Edward J. Benz, Jr. M.D.
President and CEO, Dana-Farber Cancer Institute
Melissa A. Berman
President and CEO, Rockefeller Philanthropy Advisors, Inc.
Lucy Bernholz
Founder and President, Blueprint Research & Design, Inc
Seth Berkley, M.D.
President and CEO, International AIDS Vaccine Initiative
Debra Black
Founder and Chair, Melanoma Research Alliance
Robert Blum
President and CEO, Cytokinetics, Inc.
Robi Blumenstein
President, CHDI Management/CHDI Foundation
Russell Bromley
Chief Operating Officer, Myelin Repair Foundation
Debi Brooks
Co-Founder, Michael J. Fox Foundation
G. Steven Burrill
CEO, Burrill & Company
|
| |
| C |
| |
|
Randall L. Carpenter, M.D.
Co-Founder, President and Chief Executive Officer, Seaside Therapeutics
Gail H. Cassell, Ph.D.
Vice President, Scientific Affairs and Distinguished Lilly Research Scholar, Infectious Diseases, Eli Lilly and Company
Frank Casty, M.D., FACP, FCCP
Vice President, External Medical Relations and Vice President, Technical Evaluation, U.S. Business Development of AstraZeneca PLC
Ceci Connolly
Staff Writer, Washington Post
|
| |
| D |
|
Wendy Diller
Co-Chief, Business Bureau, Biopharma Group Elsevier Business Intelligence
Mary Dwight
Vice President of Government Affairs, Cystic Fibrosis Foundation
|
| |
| E |
|
Christopher D. Earl, Ph.D.
Former CEO, BIO Ventures for Global Health
|
| F |
| |
|
Joan Flax
Board of Advisors, California Pizza Kitchen
Larry Flax
Co-CEO and Co-Chairman of the Board, California Pizza Kitchen
Stephen H. Friend, M.D., Ph.D.
President, CEO and a Co-Founder, Sage Bionetworks
|
| |
| G |
| |
|
Levi Garraway M.D., Ph.D.
Department of Medical Oncology, Dana-Farber Cancer Institute
Associate Physician, Brigham and Women's Hospital
James Geraghty
Senior Vice President, Genzyme Corp.
Kathy Giusti
Founder and CEO, Multiple Myeloma Research Consortium
George Golumbeski
Senior Vice President, Business Development, Celgene
William Greene, M.D.
Managing Director, Genentech
The Hon. James Greenwood
President and CEO, Biotechnology Industry Organization
|
| |
| H |
| |
|
Haroon Hashmi
Director, Drug Development in Asia-Pacific, Biogen Idec
Jamie Heywood
Co-Founder, PatientsLikeMe
Katie Hood
CEO, The Michael J. Fox Foundation for Parkinson's Research
|
| |
| K |
| |
|
Susan L. Kelley, M.D.
Chief Medical Officer, Multiple Myeloma Research Foundation
Hannah E. Kettler, Ph.D.
Economist and Senior Program Officer, Global Health Advocacy, Bill & Melinda Gates Foundation
Jeffrey Kindler
Chief Executive Officer and Chairman of the Board, Pfizer
|
| L |
| |
|
Alan J. Lewis, Ph.D.
President and CEO, Juvenile Diabetes Research Foundation
Brian Loew
Founder and CEO, Inspire
Christian Loucq
Director, PATH Malaria Vaccine Initiative
Susan Love, M.D.
President, Dr. Susan Love Research Foundation
|
| |
| M |
|
Amy Dockser Marcus
Staff Reporter, The Wall Street Journal
Vicki Seyfert-Margolis
Adviser, U.S. Food and Drug Administration
Shmuel Meitar
Co-Founder and Principal, Aurec Group
Douglas A. Melton, Ph.D.
Co-Director, Harvard Stem Cell Institute and Howard Hughes Medical Institute Investigator
Michael Milken
Chairman, FasterCures; Chairman, The Milken Institute
Melinda Moree
Interim CEO, BIO Ventures for Global Health
|
| |
| N |
|
Patrick Nef, Ph.D.
Executive Vice-President of Business Development, Medicines for Malaria Venture
Garry Neil, M.D.
Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson
|
| |
| P |
|
Fredric Pashkow
Executive Vice President and Chief Medical Officer, Cardax Pharmaceuticals
Stuart Peltz
President and Chief Executive Officer, PTC Therapeutics, Inc.
John Perkins
Senior Vice President and General Manager, Portfolio Management and U.S. Business
Steve Perrin, Ph.D.
Chief Executive Officer & Chief Scientific Officer, ALS Therapy Development Institute
Kyle Peterson
Managing Director, FSG Social Impact Advisors
Mike Powell, Ph.D.
General Partner, Sofinnova Ventures
Dennis Purcell
Senior Managing Director of Fund I and Fund II, Aisling Capital
|
| |
| R |
| |
|
Amy Comstock Rick
Chief Executive Officer, Parkinson's Action Network
|
| |
| S |
| |
|
Richard Seabrook, Ph.D., MBA
Head of Business Development, Wellcome Trust
Marie Schiller
Partner, Health Advances
Joshua M. Sharfstein, M.D.
Principal Deputy Commissioner, Food and Drug Administration
Robert H. Shelton
Co-Founder, Chairman & CEO, Private Access
Gregory C. Simon
Senior Vice President, Worldwide Policy, Pfizer
Jonathan W. Simons, M.D.
President and CEO, Prostate Cancer Foundation
Kathryn Smith
Managing Director, FastForward
Susan Solomon
Chief Executive Officer and Co-Founder, The New York Stem Cell Foundation
Howard R. Soule, Ph.D.
Executive Vice President, Discovery and Translation, Chief Science Officer, Prostate Cancer Foundation
Ken Stuart
President and Director, Seattle Biomedical Research Institute
|
| |
| T |
| |
|
Rudolph Tanzi, Ph.D.
Professor of Neurology, Massachusetts General Hospital
The Hon. Billy Tauzin
President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)
Elizabeth Thompson
Vice President, Health Sciences, Susan G. Komen for the Cure
|
| |
| U |
| |
|
Steve Usdin
Washington Editor, BioCentury
|
| |
| W |
|
John Walsh
CEO, Alpha-1 Foundation
Tim Walter
CEO/Executive Director, Association of Small Foundations
David Wholley
Director, Biomarkers Consortium at the Foundation for the National Institutes of Health
Greg Wiederrecht
Vice President & Head, External Scientific Affairs Worldwide Licensing & External Research Merck & Co., Inc.
Robert Wills, Ph.D.
Vice President, Alliance Management, Johnson & Johnson
Anne Wojcicki
Co-Founder and President, 23andMe
|